Title:
THERAPEUTIC AGENT USING ESTROGEN RECEPTOR β PARTIAL AGONIST HAVING ESTROGEN RECEPTOR α INHIBITING EFFECT, FOR PAIN AND/OR STRUCTURAL LESION FROM GYNECOLOGICAL DISORDER SUCH AS ENDOMETRIOSIS AND UTERUS ADENOMYOSIS
Document Type and Number:
WIPO Patent Application WO/2018/212256
Kind Code:
A1
Abstract:
[Problem] To provide a pharmaceutical agent for treatment of pain associated with a gynecological disorder and/or treatment of a structural lesion caused by a gynecological disorder. [Solution] A therapeutic agent for pain associated with a gynecological disorder and/or a structural lesion caused by the gynecological disorder, the therapeutic agent containing an estrogen receptor α inhibiting β partial agonist represented by structural formula (a), a pharmaceutically acceptable salt thereof, or a hydrate thereof as an effective component.
Inventors:
NAKAO KENICHIRO (JP)
HARADA TASUKU (JP)
TANIGUCHI FUMINORI (JP)
HARADA TASUKU (JP)
TANIGUCHI FUMINORI (JP)
Application Number:
PCT/JP2018/018997
Publication Date:
November 22, 2018
Filing Date:
May 16, 2018
Export Citation:
Assignee:
NOBELPHARMA CO LTD (JP)
NAT UNIV CORP TOTTORI UNIV (JP)
NAT UNIV CORP TOTTORI UNIV (JP)
International Classes:
A61K31/57; A61P15/08
Domestic Patent References:
| WO2017010515A1 | 2017-01-19 | |||
| WO2006098371A1 | 2006-09-21 |
Foreign References:
| JP2005239687A | 2005-09-08 | |||
| JP2004352663A | 2004-12-16 |
Download PDF:
Previous Patent: FUEL INJECTION CONTROL DEVICE
Next Patent: ADHESIVE COMPOSITION, CURED PRODUCT, LAMINATE, AND DEVICE
Next Patent: ADHESIVE COMPOSITION, CURED PRODUCT, LAMINATE, AND DEVICE